HCW Biologics Files S-1 for IPO
Ticker: HCWB · Form: S-1 · Filed: May 9, 2025 · CIK: 1828673
Sentiment: neutral
Topics: ipo, registration-statement, biotech
TL;DR
HCW Biologics just filed for an IPO. Get ready for some biotech action.
AI Summary
HCW Biologics Inc. filed an S-1 registration statement on May 9, 2025, for its initial public offering. The company, based in Miramar, Florida, is in the pharmaceutical preparations industry and is incorporated in Delaware. Hing C. Wong, Ph.D., serves as the Chief Executive Officer.
Why It Matters
This S-1 filing indicates HCW Biologics Inc. is preparing to become a publicly traded company, which could bring new capital and scrutiny to its operations in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a company filing for an IPO, HCW Biologics is in a high-growth, high-risk phase of its business cycle, typical for the biotech industry.
Key Numbers
- 333-287136 — SEC File Number (Identifies the specific SEC registration filing.)
- 0001828673 — Central Index Key (Unique identifier for the company in the SEC EDGAR system.)
Key Players & Entities
- HCW Biologics Inc. (company) — Registrant
- 20250509 (date) — Filing Date
- Hing C. Wong, Ph.D. (person) — Chief Executive Officer
- Miramar, FL (location) — Principal Executive Offices
- Clark Hill PLC (company) — Legal Counsel
- Ellenoff Grossman & Schole LLP (company) — Legal Counsel
FAQ
What is the primary purpose of this S-1 filing?
The S-1 filing is a registration statement required by the SEC for companies planning to offer securities to the public, such as in an Initial Public Offering (IPO).
When was this S-1 filing submitted?
The S-1 filing was submitted on May 9, 2025.
Who is the Chief Executive Officer of HCW Biologics Inc.?
Hing C. Wong, Ph.D. is the Chief Executive Officer of HCW Biologics Inc.
Where are HCW Biologics Inc.'s principal executive offices located?
HCW Biologics Inc.'s principal executive offices are located at 2929 N Commerce Parkway, Miramar, FL 33025.
What is the Standard Industrial Classification code for HCW Biologics Inc.?
The Standard Industrial Classification code for HCW Biologics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on May 9, 2025 by Hing C. Wong, Ph.D. regarding HCW Biologics Inc. (HCWB).